But as we described worse OS for cold tumors in our previous study (28) and as all of these tumors were not treated with ICIs, we do not expect a prognostic value of TGF-β expression for the established standard therapy regimens of HNSCC. The gene discussed is TGFB1; the disease is head and neck squamous cell carcinoma.